Skip to main content
CING
NASDAQ Life Sciences

Cingulate Inc. Expands At-The-Market Offering by $8.84 Million, Signaling Significant Dilution

Analyse IA par Wiseek
Sentiment info
Negatif
Importance info
8
Prix
$5.44
Cap. de marche
$40.508M
Plus bas 52 sem.
$3.2
Plus haut 52 sem.
$6.01
Market data snapshot near publication time

summarizeResume

Cingulate Inc. has significantly expanded its At-The-Market (ATM) offering program, increasing the maximum aggregate offering price by $8.4 million to a total of $31.9 million. Concurrently, the company filed a prospectus supplement for an additional $8.84 million under this expanded program. This substantial capital raise, representing a significant portion of the company's market capitalization, indicates a strong need for funding and will result in considerable dilution for existing shareholders. Investors should monitor the pace and pricing of these sales as they occur, as continuous share issuance can create an overhang on the stock price.


check_boxEvenements cles

  • ATM Program Expansion

    Cingulate Inc. increased the maximum aggregate offering price of its At-The-Market (ATM) offering agreement from $23,536,658 to $31,936,658.

  • New Offering Tranche

    The company filed a prospectus supplement for an additional $8,840,000 of common stock under the expanded ATM program.

  • Significant Dilution Potential

    This capital raise represents a substantial portion of the company's current market capitalization, indicating significant potential dilution for existing shareholders.


auto_awesomeAnalyse

Cingulate Inc. has significantly expanded its At-The-Market (ATM) offering program, increasing the maximum aggregate offering price by $8.4 million to a total of $31.9 million. Concurrently, the company filed a prospectus supplement for an additional $8.84 million under this expanded program. This substantial capital raise, representing a significant portion of the company's market capitalization, indicates a strong need for funding and will result in considerable dilution for existing shareholders. Investors should monitor the pace and pricing of these sales as they occur, as continuous share issuance can create an overhang on the stock price.

Au moment de ce dépôt, CING s'échangeait à 5,44 $ sur NASDAQ dans le secteur Life Sciences, pour une capitalisation boursière d'environ 40,5 M $. La fourchette de cours sur 52 semaines allait de 3,20 $ à 6,01 $. Ce dépôt a été évalué avec un sentiment de marché négatif et un score d'importance de 8 sur 10.

descriptionVoir le depot SEC principal

show_chartGraphique des prix

Partager cet article

Copied!

feed CING - Dernieres analyses

CING
Apr 28, 2026, 4:24 PM EDT
Filing Type: 424B3
Importance Score:
8
CING
Apr 14, 2026, 5:26 PM EDT
Filing Type: S-3
Importance Score:
8
CING
Mar 27, 2026, 4:01 PM EDT
Filing Type: 424B3
Importance Score:
8
CING
Mar 26, 2026, 4:24 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
CING
Mar 24, 2026, 5:14 PM EDT
Filing Type: 8-K
Importance Score:
9
CING
Mar 24, 2026, 5:13 PM EDT
Filing Type: 424B3
Importance Score:
9
CING
Mar 19, 2026, 6:00 PM EDT
Filing Type: S-3
Importance Score:
8
CING
Mar 18, 2026, 4:30 PM EDT
Filing Type: DEFA14A
Importance Score:
8
CING
Mar 18, 2026, 8:13 AM EDT
Filing Type: 10-K
Importance Score:
9
CING
Mar 18, 2026, 8:10 AM EDT
Filing Type: 8-K
Importance Score:
9